๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Are we ready to match donor and recipient in liver transplantation?

โœ Scribed by Ignazio R. Marino


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
66 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Liver regeneration in donors and adult r
โœ Junko Haga; Motohide Shimazu; Go Wakabayashi; Minoru Tanabe; Shigeyuki Kawachi; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 362 KB ๐Ÿ‘ 2 views

In living donor liver transplantation, the safety of the donor operation is the highest priority. The introduction of the right lobe graft was late because of concerns about donor safety. We investigated donor liver regeneration by the types of resected segments as well as recipients to assess that

Quantitative liver function tests in don
โœ Christoph Jochum; Mechthild Beste; Volker Penndorf; Marjan Sharifi Farahani; Giu ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB

The unique ability of the liver to regenerate quickly after resection makes living donor liver transplantation (LDLT) possible. This technique uses the unique ability of the liver to regenerate to full size after partial resection. However, the quality and course of this regeneration process in huma

Cytomegalovirus in liver transplant reci
โœ Nada Rayes; Daniel Seehofer; Peter Neuhaus ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 37 KB

In their article, Singh et al. describe their protocol on preemptive therapy in CMV pp65-antigen positive liver transplant recipients, 1 which was implemented 13 years ago and led to a decrease of CMV disease. In their view, preemptive therapy is superior to general prophylaxis, although prospective

Influence of donor/recipient HLA-matchin
โœ Jan Michael Langrehr; Gero Puhl; Marcus Bahra; Maximilian Schmeding; Antonino Sp ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB

The aim of this study was to analyze the effect of human leukocyte antigen (HLA) matching on outcome, severity of recurrent hepatitis C and risk of rejection in hepatitis C positive patients after liver transplantation (LT). In a retrospective analysis, 165 liver transplants in patients positive for